Гемофагоцитарный синдром и саркома Капоши после трансплантации печени

Гемофагоцитарный синдром (гемофагоцитарный лимфогистиоцитоз, синдром активированных макрофагов) является особой формой генерализованной воспалительной реакции организма и определяется такими неспецифическими симптомами, как лихорадка, лимфаденопатия, гепатоспленомегалия, цитопения. Часто триггером для развития вторичного гемофагоцитарного синдрома служит инфекционный процесс. Мы описываем случай пациента, перенесшего трансплантацию печени, у которого гемофагоцитарный синдром развился на фоне инфекции вирусом Эпштейна–Барр и вирусом герпеса человека 8-го типа. На момент написания статьи в литературе приводятся 22 случая гемофагоцитарного синдрома после трансплантации печени и всего 1 наблюдение сочетания гемофагоцитарного синдрома с саркомой Капоши и инфекцией вируса Эпштейна–Барр у реципиента печени. В процессе диагностики данного синдрома возникает много сложностей, обусловленных неспецифичностью симптомов. Своевременное уточнение диагноза и раннее начало терапии необходимы в связи с быстрым прогрессированием болезни.

1. Janka G.E. Familial and acquired hemophagocytic lymphohistiocytosis. Annu. Rev. Med. 2012;63:233–246. DOI:10.1146/annurev-med-041610-134208

2. Risdall R.J., Mckenna R.W., Nesbit M.E., et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer. 1979;44(3):993–1002. PMID:225008

3. Perez N., Virelizier J.L., ArenzanaSeisdedos F., et al. Impaired natural killer activity in lymphohistiocytosis syndrome. J. Pediatr. 1984;104(4):569–573. PMID:6368780

4. Ramachandran S., Zaidi F., Aggarwal A., et al. Recent advances in diagnostic and therapeutic guidelines for primary and secondary hemophagocytic lymphohistiocytosis. Blood Cells Mol. Dis. 2017;64:53–57. DOI:10.1016/j.bcmd.2016.10.023

5. Chisuwa H., Hashikura Y., Nakazawa Y., et al. Fatal hemophagocytic syndrome after living-related liver transplantation: a report of two cases. Transplantation. 2001;72(11):1843–1846. PMID:11740400

6. Soyama A., Eguchi S., Takatsuki M., et al. Hemophagocytic syndrome after liver transplantation: report of two cases. Surg. Today. 2011;41(11):1524–1530. DOI:10.1007/s00595-010-4512-9

7. Karasu Z., Kilic M., Cagirgan S., et al. Hemophagocytic syndrome after living-related liver transplantation. Transplant. Proc. 2003;35(4):1482–1484. PMID:12826200

8. Llado L., Figueras J., Comi S., et al. Haemophagocytic syndrome after liver transplantation in adults. Transpl. Int. 2004;17(4):221–223. DOI:10.1007/s00147004-0696-5

9. George T.I., Jeng M., Berquist W., et al. Epstein-Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: case report and review of the literature. Pediatr. Blood Cancer. 2005;44(3):270–276. DOI:10.1002/pbc.20231

10. Taniai N., Akimaru K., Kawano Y., et al. Hemophagocytic syndrome after living-donor liver transplantation for fulminant liver failure: a case report. Hepatogastroenterology. 2005;52(63):923–926. PMID:15966233

11. Hardikar W., Pang K., Al-Hebbi H., et al. Successful treatment of cytomegalovirus-associated haemophagocytic syndrome following paediatricorthotopic liver transplantation. J. Paediatr. Child Health. 2006;42(6):389–391. DOI:10.1111/j.1440-1754.2006.00879.x

12. Akamatsu N., Sugawara Y., Tamura S., et al. Hemophagocytic syndrome after adult-to-adult living donor liver transplantation. Transplant. Proc. 2006;38(5):1425–1428. DOI:10.1016/j.transproceed.2006.02.089

13. Yoshizumi T., Taketomi A., Kayashima H., et al. Successful treatment for a patient with hemophagocytic syndrome after a small-for-size graft liver transplantation. Hepatogastroenterology. 2008;55(82–83):359–362. PMID:18613366

14. Dharancy S., Crombe V., Copin M.C., et al. Fatal hemophagocytic syndrome related to human herpesvirus-6 reinfection following liver transplantation: a case report. Transplant. Proc. 2008;40(10):3791–3793. DOI:10.1016/j.transproceed.2008.05.083

15. Zhang M., Guo C., Yan L., et al. Successful treatment of Epstein-Barr Virusassociated haemophagocytic syndrome arising after living donor liver transplantation. Hepatol. Res. 2009;39(4):421–426. DOI:10.1111/j.1872-034X.2008.00463.x

16. Satapathy S.K., Isabel Fiel M., Del Rio Martin J., et al. Hemophagocytic syndrome occurring in an adult liver transplant recipient having Still's disease. Hepatol. Int. 2010;5(1):597–602. DOI:10.1007/s12072-010-9218-y

17. Shabbir M., Lucas J., Lazarchick J., Shirai K. Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature. Hematol. Oncol. 2011;29(2):100–106. DOI:10.1002/hon.960

18. Imura S., Shimada M., Saito Y., et al. Successful case with hemophagocytic syndrome after living donor liver transplantation. Hepatogastroenterology. 2012;59(115):863–865. DOI:10.5754/hge10081

19. Fu B.S., Yang Y., Li H., et al. Hemophagocytic syndrome: a rare but fatal complication after liver transplantation. Chin. Med. J. (Engl). 2013;126(18):3587–3589. PMID:24034118

20. Rodriguez-Medina B., Blanes M., Vinaixa C., et al. Haemophagocytic syndrome in a liver transplant patient during treatment with Telaprevir. Ann. Hepa tol. 2013;12(6):974–978. PMID:24114830

21. Okada N., Sanada Y., Hirata Y., et al. The impact of rituximab in AB0incompatible pediatric living donor liver transplantation: the experience of a single center. Pediatr. Transplant. 2015;19(3):279–286. DOI:10.1111/petr.12445

22. Vijgen S., Wyss C., Meylan P., et al. Fatal Outcome of Multiple Clinical Presentations of Human Herpesvirus 8-related Disease After Solid Organ Transplantation. Transplantation. 2016;100(1):134–140. DOI:10.1097/TP.0000000000000801

23. Прокопенко Е., Щербакова Е., Ватазин А. и др. Панцитопения и гемофагоцитарный синдром после трансплантации почки (Обзор литературы с клиническим наблюдением). Нефрология и диализ. 2010;12(2):82–89.

24. Karras A., Thervet E., Legendre C. Hemophagocytic syndrome in renal transplant recipients: report of 17 cases and review of literature. Transplantation. 2004;77(2):238–243. DOI:10.1097/01.TP.0000107285.86939.37

25. Beutel K., Gross-Wieltsch U., Wiesel T., et al. Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin. Pediatr. Blood Cancer. 2009;53(2):184–190. DOI:10.1002/pbc.22037

26. Kawaguchi H., Miyashita T., Herbst H., et al. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virusassociated hemophagocytic syndrome. J. Clin. Invest. 1993;92(3):1444–1450. DOI:10.1172/JCI116721

27. Lucey M.R., Terrault N., Ojo L., et al. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 2013;19(1):3–26. DOI:10.1002/lt.23566

28. Riva G., Luppi M., Barozzi P., et al. How I treat HHV8/KSHV-related di seases inposttransplant patients. Blood. 2012;120(20):4150–4159. DOI:10.1182/blood-2012-04-421412

29. Fardet L., Blum L., Kerob D., et al. Human herpesvirus 8-associated hemophagocytic lymphohistiocytosis in human immunodeficiency virus-infected patients. Clin. Infect. Dis. 2003;37(2):285– 291. DOI:10.1086/375224

30. Park Y.J., Bae H.J., Chang J.Y., et al. Development of Kaposi sarcoma and hemophagocytic lymphohistiocytosis associated with human herpesvirus 8 in a renal transplant recipient. Korean J. Intern. Med. 2017;32(4):750–752. DOI:10.3904/kjim.2015.124

31. Allen C.E., Yu X., Kozinetz C.A., et al.Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer. 2008;50(6):1227–1235. DOI:10.1002/pbc.21423

32. Henter J.I., Arico M., Egeler R.M., et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med. Pediatr. Oncol. 1997;28(5):342– 347. PMID:9121398

33. Henter J.I., Horne A., Arico M., et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer. 2007;48(2):124–131. DOI:10.1002/pbc.21039

34. Polizzotto M.N., Uldrick T.S., Wyvill K.M., et al. Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS). Clin. Infect. Dis. 2016;62(6):730–738. DOI:10.1093/cid/civ996

35. Mularoni A., Gallo A., Riva G., et al. Successful Treatment of Kaposi Sarcoma-Associated Herpesvirus Inflammatory Cytokine Syndrome After Kidney-Liver Transplant: Correlations With the Human Herpesvirus 8 miRNome and Specific T Cell Response. Am. J. Transplant. 2017;17(11):2963–2969. DOI:10.1111/ajt.14346

36. Kleynberg R.L., Schiller G.J. Secondary hemophagocytic lymphohistiocytosis in adults: an update on diagnosis and therapy. Clin. Adv.Hematol. Oncol. 2012;10(11):726–732. PMID:23271259

37. Imashuku S., Kuriyama K., Sakai R., et al. Treatment of Epstein-Barr virusassociated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center. Med. Pediatr. Oncol. 2003;41(2):103–109. DOI:10.1002/mpo.10314

38. Chellapandian D., Das R., Zelley K.,et al. Treatment of Epstein Barr virusinduced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. Br. J. Haematol. 2013;162(3):376–382. DOI:10.1111/bjh.12386

39. Marsh R.A., Allen C.E., Mcclain K.L., et al. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. Pediatr. Blood Cancer. 2013;60(1):101–109. DOI:10.1002/pbc.24188

40. Stallone G., Schena A., Infante B., et al.Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N. Engl. J. Med. 2005;352(13):1317–1323. DOI:10.1056/NEJMoa042831

41. Thaunat O., Mamzer-Bruneel M.F., Agbalika F., et al. Severe human herpesvirus-8 primary infection in a renal transplant patient successfully treated with anti-CD20 monoclonal antibody. Blood. 2006;107(7):3009–3010. DOI:10.1182/blood-2005-08-3213